Sodium-glucose cotransporter 2 inhibitors may increase iron availability with beneficial effects on erythropoiesis and cardiovascular mortality in patients with type 2 diabetes mellitus. Author's Reply.

Saved in:
Bibliographic Details
Title: Sodium-glucose cotransporter 2 inhibitors may increase iron availability with beneficial effects on erythropoiesis and cardiovascular mortality in patients with type 2 diabetes mellitus. Author's Reply.
Authors: Cannarella R; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy; Glickman Urological and Kidney Institute, Cleveland Clinic, Cleveland, OH, USA. Electronic address: rossella.cannarella@unict.it., Rubulotta M; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy., Cannarella V; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy; Dipartimento di Scienze Mediche, IOC di Medicina Generale, AOU Policlinico 'G. Rodolico-San Marco', University of Catania, Catania, Italy., La Vignera S; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy., Calogero AE; Department of Clinical and Experimental Medicine, University of Catania, Catania, Italy.
Source: European journal of internal medicine [Eur J Intern Med] 2025 Nov; Vol. 141, pp. 106516. Date of Electronic Publication: 2025 Sep 22.
Publication Type: Letter
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 9003220 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0828 (Electronic) Linking ISSN: 09536205 NLM ISO Abbreviation: Eur J Intern Med Subsets: MEDLINE; In Process
Database: MEDLINE Ultimate
Description
ISSN:1879-0828
DOI:10.1016/j.ejim.2025.106516